Emflaza asset acquisition (Tables)

12 Months Ended

Dec. 31, 2017

The following tables present the total purchase consideration and the preliminary allocation of the purchase consideration for the Transaction as of April 20, 2017 (the “Acquisition Date”):



Cash consideration	$	75,000
Fair value of PTC common stock issued to Marathon (6,683,598 shares)	75,190
Acquisition costs	2,163
Total preliminary consideration transferred	$	152,353

Schedule of recognized identified assets acquired and liabilities assumed



Purchase price	$	152,353

Total fair value of tangible assets acquired and liabilities assumed:
Inventory	3,980
Emflaza rights	$	148,373

Schedule of finite-lived intangible assets, future amortization expense

As of December 31, 2017, the Company recognized accumulated amortization of $15.4 million with respect to the Emflaza rights intangible asset. The estimated future amortization of the Emflaza rights intangible asset is expected to be as follows:



	As of December 31, 2017
2018	$	21,713
2019	21,713
2020	21,713
2021	21,713
2022 and thereafter	46,141
Total	$	132,993